THU617 Prolonged Exposure To Target Mitotane Concentrations Is Associated With Better Recurrence-free Survival In Patients With Adrenocortical Carcinoma On Adjuvant Treatment

Disclosure: S. Puglisi: None. A. Calabrese: None. V. Basile: None. O. Kimpel: Speaker; Self; HRA Pharmaceuticals. B. Altieri: None. A. Angelousi: None. G. Kaltsas: None. U. Ambroziak: None. M.L. Appetecchia: None. M. Arosio: None. A. Berruti: Advisory Board Member; Self; HRA Pharmaceuticals. D. Cose...

Descripción completa

Detalles Bibliográficos
Autores principales: Puglisi, Soraya, Calabrese, Anna, Basile, Vittoria, Kimpel, Otilia, Altieri, Barbara, Angelousi, Anna, Kaltsas, Gregory, Ambroziak, Urszula, Appetecchia, Maria Luisa, Arosio, Maura, Berruti, Alfredo, Cosentini, Deborah, Canu, Letizia, Ceccato, Filippo, Di Dalmazi, Guido, Bouys, Lucas, Libè, Rossella, Nowak, Karolina, Papierska, Lucyna, Pittaway, James, Kienitz, Tina, Quinkler, Marcus, Elhassan, Yasir, Ronchi, Cristina, Saiegh, Leonard, Stigliano, Antonio, Dusek, Tina, Kastelan, Darko, Fassnacht, Martin, Terzolo, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Adrenal (Excluding Mineralocorticoids)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555167/
http://dx.doi.org/10.1210/jendso/bvad114.147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555167/
http://dx.doi.org/10.1210/jendso/bvad114.147

Ejemplares similares